Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guidelines – Renal Cell Carcinoma

Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Published online: 22 May 2024 - Annals of Oncology
Powles T, Albiges L, Bex A, et al., on behalf of the ESMO Guidelines Committee

  • This ESMO Clinical Practice Guideline provides key recommendations for managing renal cell carcinoma.
  • The guideline covers imaging and diagnosis, staging and risk assessment, treatment and follow-up.
  • Algorithms for the management of localised and advanced or metastatic disease are provided.
  • The authors comprise a multidisciplinary group of experts from different institutions and countries.
  • Recommendations are based on available scientific data and the authors’ collective expert opinion.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.